CLSD: the cash flow

Cash Flow Overview

Change in Cash

-$2,575K

Free Cash flow

-$5,480K

Unit: Thousand (K) dollars

Positive Cash Flow Breakdown

Negative Cash Flow Breakdown

Cash Flow

2025-09-30

2025-06-30

Net loss

-5,972

-12,718

Non-cash interest expense on liability related to the sales of future royalties, net of issuance costs accretion

2,570

5,435

Depreciation

169

Share-based compensation expense

746

1,415

Change in fair value of warrant liabilities

-3,573

-1,927

Issuance costs allocated to warrant liabilities

Amortization and accretion of available-for-sale investments, net

Prepaid expenses and other current assets

-956

1,155

Other assets and liabilities

Accounts payable and accrued liabilities (includes 223 to a related party for the nine months ended september 30, 2024)

-280

-1,753

Deferred revenue

Net cash used in operating activities

-5,480

-10,559

Acquisition of property and equipment

Purchase of short-term investments

Maturity of short-term investments

Net cash used in investing activities

-9

Proceeds from issuance of common stock and warrants under registered direct offering, net of issuance costs

Proceeds from at-the-market sales agreement, net of issuance costs

1,411

Proceeds from royalty purchase and sale agreement, net of issuance cost

2,895

Payments on royalty purchase and sale agreement

1,500

Proceeds from exercise of stock options

Proceeds from shares issued under employee stock purchase plan

Net cash provided by financing activities

2,905

-76

Net decrease in cash and cash equivalents

-2,575

-10,644

Cash and cash equivalents at beginning of period

20,020

Cash and cash equivalents at end of period

6,801

Time Plot

Show the time plot by selecting a row from the table.